VULVOVAGINAL EXFOLIATION

VULVOVAGINAL EXFOLIATION was reported 52 times

VULVOVAGINAL EXFOLIATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Plasma Kallikrein Inhibitor [EPC] 1 0.0004
1 Provitamin D2 Compound [EPC] 7 0.0002
2 Non-Standardized Insect Allergenic Extract [EPC] 1 0.0002
3 Standardized Insect Venom Allergenic Extract [EPC] 1 0.0001
4 Estrogen Receptor Antagonist [EPC] 4 0.0001
5 Azole Antifungal [EPC] 12 0.0001
6 Non-Standardized Food Allergenic Extract [EPC] 5 0.0001
7 Nitrofuran Antibacterial [EPC] 1 0.0001
8 Non-Standardized Plant Allergenic Extract [EPC] 1 0.0001
9 Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] 1 0.0000
10 Androgen [EPC] 1 0.0000
11 Aromatase Inhibitor [EPC] 4 0.0000
12 Angiotensin Converting Enzyme Inhibitor [EPC] 3 0.0000
13 Copper-containing Intrauterine Device [EPC] 1 0.0000
14 Expectorant [EPC] 4 0.0000
15 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1 0.0000
16 Methylxanthine [EPC] 1 0.0000
17 Sulfonylurea [EPC] 2 0.0000
18 Nitroimidazole Antimicrobial [EPC] 1 0.0000
19 HMG-CoA Reductase Inhibitor [EPC] 5 0.0000
20 Non-Standardized Chemical Allergen [EPC] 1 0.0000
21 Catecholamine [EPC] 1 0.0000
22 Central Nervous System Stimulant [EPC] 1 0.0000
23 Serotonin Reuptake Inhibitor [EPC] 1 0.0000
24 Estrogen [EPC] 2 0.0000
25 Interleukin-23 Antagonist [EPC] 1 0.0000
26 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1 0.0000
27 P2Y12 Platelet Inhibitor [EPC] 1 0.0000
28 Interleukin-4 Receptor alpha Antagonist [EPC] 4 0.0000
29 Insulin Analog [EPC] 2 0.0000
30 Nonsteroidal Anti-inflammatory Drug [EPC] 5 0.0000
31 beta-Adrenergic Blocker [EPC] 1 0.0000
32 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
33 Tumor Necrosis Factor Blocker [EPC] 3 0.0000
34 Vitamin C [EPC] 1 0.0000
35 GLP-1 Receptor Agonist [EPC] 1 0.0000
36 Loop Diuretic [EPC] 1 0.0000
37 Thalidomide Analog [EPC] 1 0.0000
38 Platelet Aggregation Inhibitor [EPC] 1 0.0000
39 Proton Pump Inhibitor [EPC] 1 0.0000
40 Corticosteroid [EPC] 1 0.0000